About Linda Alunkal
Linda Alunkal is co-founder and chief executive officer of BioLattice Ophthalmics in Philadelphia. The company develops CorneaClear, an engineered cornea meant as an alternative to donor cornea tissue. She co-founded it with Amelia Zellander. BioLattice announced her promotion to chief executive officer on January 26, 2026.
Alunkal is a Penn State chemical engineering graduate. On October 29, 2026, Penn State announced that its Nittany Angels network had committed $500,000 to BioLattice, which had recently closed its first seed round.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Linda Alunkal in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Linda Alunkal works with at each company, as listed on that company's latest Form D.
